Abstract |
Endomorphin-2 (Tyr-Pro-Phe-Phe-NH2) binds with high affinity and selectivity to the mu-opioid receptor. In the present study, [125I] endomorphin-2 has been used to characterize mu- opioid-binding sites on transplantable mouse mammary adenocarcinoma cells. Cold saturation experiments performed with [125I] endomorphin-2 (1 nM) show biphasic binding curves in Scatchard coordinates. One component represents high affinity and low capacity (K(d) = 18.79 +/- 1.13 nM, B(max) = 635 +/- 24 fmol/mg protein) and the other shows low affinity and higher capacity (K(d) = 7.67 +/- 0.81 microM, B(max) = 157 +/- 13 pmol/mg protein) binding sites. The rank order of agonists competing for the [125I] endomorphin-2 binding site was [d-1-Nal3] morphiceptin > endomorphin-2 >> [d-Phe3] morphiceptin > morphiceptin > [d-1-Nal3] endomorphin-2, indicating binding of these peptides to mu-opioid receptors. The uptake of 131I-labeled peptides administered intraperitoneally to tumor-bearing mice was also investigated. The highest accumulation in the tumor was observed for [d-1-Nal3) morphiceptin, which reached the value of 8.19 +/- 1.14% dose/g tissue.
|
Authors | J Fichna, J-C do-Rego, M Mirowski, J Costentin, A Janecka |
Journal | The journal of peptide research : official journal of the American Peptide Society
(J Pept Res)
Vol. 65
Issue 4
Pg. 459-64
(Apr 2005)
ISSN: 1397-002X [Print] Denmark |
PMID | 15813894
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Iodine Radioisotopes
- Oligopeptides
- Receptors, Opioid, mu
- endomorphin 2
|
Topics |
- Adenocarcinoma
(metabolism)
- Animals
- Binding, Competitive
- Cell Membrane
(metabolism)
- Female
- Iodine Radioisotopes
(metabolism)
- Mammary Neoplasms, Experimental
(metabolism)
- Mice
- Mice, Inbred C3H
- Oligopeptides
(metabolism)
- Receptors, Opioid, mu
(metabolism)
|